K261379Substantially Equivalent
BD Veritor System for SARS-CoV-2
BD Diagnostic Solutions / Becton, Dickinson & Company, Sparks MD / Dual Track, Substantially Equivalent
Clearance record
- Decision date
- Received
- (183 days to decision)
- Product code
- QVF Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient Settings
- Regulation
- 21 CFR 866.3982
- Device class
- Class II
- Review panel
- Microbiology
- Applicant
- BD Diagnostic Solutions / Becton, Dickinson & Company 7 Loveton Cir., Sparks MD
- 510(k) summary
- Summary PDF
- Third party review
- No
Clearances, product code QVF
Trailing 12 monthsShow the numbers
| Month | Clearances |
|---|---|
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 0 |
| March 2026 | 0 |
| April 2026 | 0 |
| May 2026 | 0 |
| June 2026 | 1 |
| July 2026 | 0 |
| August 2026 | 0 |
| September 2026 | 1 |
| October 2026 | 1 |
| November 2026 | 0 |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
